Retatrutide Study Assesses Impact on Diabetes Patients with Obesity or Overweight | Retatrutide News

A study on retatrutide for type 2 diabetes patients with obesity has been completed. The trial lasted 89 weeks and included up to 24 visits.
Clinical Trials · October 22, 2026